-
Something wrong with this record ?
Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis
V. Bahlinger, R. Stoehr, A. Hartmann, O. Hes, A. Agaimy
Language English Country Germany
Document type Journal Article, Comparative Study
NLK
ProQuest Central
from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2003-01-01 to 1 year ago
- MeSH
- Cell Differentiation MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Carcinoma, Small Cell * genetics pathology MeSH
- Mutation MeSH
- Biomarkers, Tumor * genetics analysis MeSH
- Urinary Bladder Neoplasms * pathology genetics MeSH
- Carcinoma, Neuroendocrine * pathology genetics MeSH
- Rhabdomyosarcoma * genetics pathology MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Telomerase genetics MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Rhabdomyosarcoma (RMS) of the urinary bladder in adults and elderly is an exceptionally rare neoplasm that displays poorly differentiated solid (alveolar-like) small cell pattern, frequently indistinguishable from small cell neuroendocrine carcinoma (SCNEC). However, the histogenesis of RMS and SCNEC and their inter-relationship have not been well studied and remained controversial. We herein analyzed 23 SCNEC and 3 small round cell RMS of the bladder for neuroendocrine (synaptophysin + chromogranin A) and myogenic (desmin + myogenin) marker expression and for TERT promoter mutations. In addition, the RMS cohort and one SCNEC that was revised to RMS were tested for gene fusions using targeted RNA sequencing (TruSight Illumina Panel which includes FOXO1 and most of RMS-related other genes). Overall, significant expression of myogenin and desmin was observed in one of 23 original SCNEC justifying a revised diagnosis to RMS. On the other hand, diffuse expression of synaptophysin was noted in 2 of the 4 RMS, but chromogranin A was not expressed in 3 RMS tested. TERT promoter mutations were detected in 15 of 22 (68%) SCNEC and in two of three (67%) assessable RMS cases, respectively. None of the four RMS cases had gene fusions. Our data highlights phenotypic and genetic overlap between SCNEC and RMS of the urinary bladder. High frequency of TERT promoter mutations in SCNEC is in line with their presumable urothelial origin. In addition, the presence of TERT promoter mutation in 2 of 3 RMS and lack of FOXO1 and other gene fusions in all 4 RMSs suggest a mucosal (urothelial) origin, probably representing extensive monomorphic rhabdomyoblastic transdifferentiation in SCNEC.
Comprehensive Cancer Center Erlangen EMN Erlangen Germany
Institute of Pathology Friedrich Alexander University Erlangen Nürnberg Erlangen Germany
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25004070
- 003
- CZ-PrNML
- 005
- 20250206105116.0
- 007
- ta
- 008
- 250121s2024 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-024-03835-3 $2 doi
- 035 __
- $a (PubMed)38833173
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Bahlinger, Veronika $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen (UKER), Erlangen, Germany $u Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany $u Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tubingen, Tubingen, Germany
- 245 10
- $a Small cell neuroendocrine carcinoma and poorly differentiated rhabdomyosarcomas of the urinary bladder in adults-A comparative analysis in favor of a common histogenesis / $c V. Bahlinger, R. Stoehr, A. Hartmann, O. Hes, A. Agaimy
- 520 9_
- $a Rhabdomyosarcoma (RMS) of the urinary bladder in adults and elderly is an exceptionally rare neoplasm that displays poorly differentiated solid (alveolar-like) small cell pattern, frequently indistinguishable from small cell neuroendocrine carcinoma (SCNEC). However, the histogenesis of RMS and SCNEC and their inter-relationship have not been well studied and remained controversial. We herein analyzed 23 SCNEC and 3 small round cell RMS of the bladder for neuroendocrine (synaptophysin + chromogranin A) and myogenic (desmin + myogenin) marker expression and for TERT promoter mutations. In addition, the RMS cohort and one SCNEC that was revised to RMS were tested for gene fusions using targeted RNA sequencing (TruSight Illumina Panel which includes FOXO1 and most of RMS-related other genes). Overall, significant expression of myogenin and desmin was observed in one of 23 original SCNEC justifying a revised diagnosis to RMS. On the other hand, diffuse expression of synaptophysin was noted in 2 of the 4 RMS, but chromogranin A was not expressed in 3 RMS tested. TERT promoter mutations were detected in 15 of 22 (68%) SCNEC and in two of three (67%) assessable RMS cases, respectively. None of the four RMS cases had gene fusions. Our data highlights phenotypic and genetic overlap between SCNEC and RMS of the urinary bladder. High frequency of TERT promoter mutations in SCNEC is in line with their presumable urothelial origin. In addition, the presence of TERT promoter mutation in 2 of 3 RMS and lack of FOXO1 and other gene fusions in all 4 RMSs suggest a mucosal (urothelial) origin, probably representing extensive monomorphic rhabdomyoblastic transdifferentiation in SCNEC.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a nádory močového měchýře $x patologie $x genetika $7 D001749
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a neuroendokrinní karcinom $x patologie $x genetika $7 D018278
- 650 12
- $a rhabdomyosarkom $x genetika $x patologie $7 D012208
- 650 12
- $a malobuněčný karcinom $x genetika $x patologie $7 D018288
- 650 12
- $a nádorové biomarkery $x genetika $x analýza $7 D014408
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a telomerasa $x genetika $7 D019098
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Stoehr, Robert $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen (UKER), Erlangen, Germany $u Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
- 700 1_
- $a Hartmann, Arndt $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen (UKER), Erlangen, Germany $u Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
- 700 1_
- $a Hes, Ondřej $u Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Plzen, Czech Republic
- 700 1_
- $a Agaimy, Abbas $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen (UKER), Erlangen, Germany. abbas.agaimy@uk-erlangen.de $u Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. abbas.agaimy@uk-erlangen.de
- 773 0_
- $w MED00004660 $t Virchows Archiv $x 1432-2307 $g Roč. 485, č. 4 (2024), s. 615-623
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38833173 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206105112 $b ABA008
- 999 __
- $a ok $b bmc $g 2263678 $s 1240077
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 485 $c 4 $d 615-623 $e 20240604 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- LZP __
- $a Pubmed-20250121
